Nova Scotia will join the other provinces and territories in a working group studying a controversial treatment for multiple sclerosis.
Health Minister Maureen MacDonald told Metro yesterday the group’s mandate will be to gather information from clinical trials and research into liberation treatment. MacDonald said the working group is scheduled to report back its findings within a year. The province will then decide whether starting clinical trials is feasible and ethical.
“The objective of the group is to … look at what research is occurring right now on this,” said MacDonald, calling from a health ministers meeting in St. John’s. “We agreed that we would move to clinical trials when the evidence is there.” The news comes on the same day as Newfoundland’s announcement it will devote funds to clinical trials of the treatment, developed by the Italian physician Dr. Paolo Zamboni.
